Growth Metrics

Crescent Biopharma (CBIO) Cash & Equivalents Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -68.22%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 988.88%
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 15.64%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 4.77%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 17.50%
7 Evaxion A 64.16 Bn 64.14 Bn - 3.35%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -4.13%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 67.78%
10 Crescent Biopharma 569.36 Mn 380.20 Mn - 743.39%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 743.39%
Dec 31, 2025 513.22%
Sep 30, 2025 825.45%
Mar 31, 2025 -28.30%
Dec 31, 2024 -16.81%
Sep 30, 2024 -70.85%
Jun 30, 2024 -61.40%
Mar 31, 2024 -51.88%
Dec 31, 2023 -12.70%
Sep 30, 2023 -4.25%
Jun 30, 2023 -3.59%
Mar 31, 2023 -15.05%
Dec 31, 2022 -46.96%
Sep 30, 2022 -49.37%
Jun 30, 2022 -49.35%
Mar 31, 2022 -42.24%
Dec 31, 2021 -34.14%
Sep 30, 2021 -28.66%
Mar 31, 2021 -14.44%
Dec 31, 2020 -13.38%
Sep 30, 2020 -16.39%
Mar 31, 2020 -20.83%
Dec 31, 2019 -24.64%
Sep 30, 2019 -22.26%
Jun 30, 2019 -19.73%
Mar 31, 2019 -19.40%
Dec 31, 2018 69.39%
Sep 30, 2018 94.76%
Jun 30, 2018 92.56%
Mar 31, 2018 601.44%
Dec 31, 2017 209.49%
Sep 30, 2017 149.26%
Jun 30, 2017 124.45%
Mar 31, 2017 -10.92%
Dec 31, 2016 -14.45%
Sep 30, 2016 -15.77%
Jun 30, 2016 31.94%
Mar 31, 2016 -16.61%
Dec 31, 2015 -15.21%
Sep 30, 2015 -12.39%
Jun 30, 2015 -39.24%
Mar 31, 2015 -18.25%
Dec 31, 2014 2,288.94%
Sep 30, 2014 697.99%
Jun 30, 2014 514.38%
Mar 31, 2014 322.30%